Migraleve Pink Tablets

Name: Migraleve Pink Tablets
Brand: Pharmacy Only
SKU: MIG000PA
Price: 5.99 GBP
Availability: InStock

£5.99

Pack Size 12

Product variants

£5.99

Tax included. Shipping calculated at checkout.

Pharmacy medicine

Start your order online

1Answer a short medical questionnaire
2Pay securely at checkout
3Our pharmacist reviews your order before dispatch

Start consultation

You will log in or create an account first, then return to this treatment and continue straight to the questionnaire.

Dispensed in Streatham
GPhC-registered pharmacy
Discreet packaging

Need Express Delivery? Order now!

I18n Error: Missing interpolation value "end_date" for "Ends on {{ end_date }}"

BUY WITH CONFIDENCE

Westbury Chemist is a GPhC-registered pharmacy (Registration No. 1041186) operated by qualified pharmacists, providing professional and regulated healthcare services

Shop safely with us

copy-of-migraleve-tablets Description

Migraleve Pink Tablets should be taken orally.

The usual dose for adults and children over 12 years of age is two tablets at the first sign of a migraine attack.

If the headache persists, take two further tablets after four hours.

Do not exceed six tablets (3 doses) in any 24-hour period.

These tablets should not be used continuously for more than three days. If your headache persists, seek medical advice.

Swallow the tablets whole with a glass of water, do not chew them.

Migraleve Pink Tablets are not recommended for children under 12 years of age.

Remember this is a guide, always check the patient information leaflet provided and consult your doctor or pharmacist if unsure about how to take this medication.

Paracetamol, Codeine Phosphate, Buclizine Hydrochloride

Allergic reactions: It may cause skin rashes, itching, swelling, and difficulty breathing.

Common side effects: Include dizziness, drowsiness, constipation, and nausea.

Low blood pressure and slow heartbeat: Patients with heart diseases or blood pressure-related issues should use with caution.

Mental health impact: It may cause confusion, restlessness, and mood changes. Precautions should be taken if you have a mental health condition.

Alcohol interaction: Alcohol can increase the risk of side effects such as drowsiness and dizziness. Avoid drinking alcohol while taking this medicine.

Dependency & Withdrawal: Long-term use of this medicine can lead to dependency. Abrupt discontinuation may result in withdrawal symptoms.

Not suitable for some individuals: People with liver or kidney disease, bowel problem, pregnant or breastfeeding women should avoid using this tablet.

Always consult with a healthcare professional before starting any medication.

Not suitable for children under 12 years of age.

Do not take if pregnant or breastfeeding, unless advised by a doctor.

Avoid consumption if allergic to any of the ingredients.

Can cause drowsiness; don't drive or operate machinery if affected.

Avoid drinking alcohol while taking this medication.

Do not take more than the recommended dose.

Consult your doctor if symptoms persist or worsened after a few days of taking the medicine.

Migraleve Pink Tablets may interact with other drugs. Inform your doctor if you're taking other medications.

Not advisable for individuals with severe heart, liver, or kidney problems.

Inform your doctor if you have high blood pressure, diabetes, or other health conditions.

Patient Information Leaflet

Always Read The Patient Information Leaflet

Medicines can cause side effects. Always read the leaflet that comes with your medication and report any side effects to your pharmacist.

Read the patient information leaflet on the emc

The electronic medicines compendium (emc) publishes the official leaflets for licensed UK medicines.

Meet our clinicians

Every online consultation is reviewed by one of our pharmacists before any medicine is supplied. Each clinician is registered with the General Pharmaceutical Council, and you can check their registration using the Verify link.

Superintendent Pharmacist and Independent Prescriber

Oluwole Ososami

Leads clinical governance at Westbury Chemist. Clinical interests include acute respiratory conditions, urinary tract infections and musculoskeletal conditions.

GPhC 2047506

Verify